Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host dermal connective tissue, commonly known as the dermis, is the thick layer of skin located between the epidermis and the subcutaneous fat. It is primarily composed of an extracellular matrix (ECM) containing collagen and elastic fibers, which provide the skin with essential tensile strength and elasticity (StatPearls, 2023). The dermis serves as a home for various specialized structures, including blood vessels, lymphatics, nerves, hair follicles, and sweat glands, and it plays a vital role in thermoregulation and sensory perception (NIH, 2022). Within this tissue, fibroblasts are the predominant cell type responsible for synthesizing the ECM, while resident immune cells provide a first line of defense against pathogens. In clinical practice, the dermal connective tissue is the site of pathology for numerous conditions such as systemic sclerosis, keloids, and chronic wounds (PubMed, 2021). While the tissue itself is an anatomical structure rather than a single molecular target, its individual components—such as specific collagen types or enzymes like matrix metalloproteinases—are frequently targeted by pharmacological agents to treat skin aging, inflammation, and fibrotic disorders.
Drugs interacting with this tissue typically function by enzymatically degrading extracellular matrix components, providing structural volume through supplementation, stimulating fibroblast activity to increase collagen synthesis, or suppressing local inflammatory cytokine production within the dermal environment (StatPearls, 2023; PubMed, 2021).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dermal connective tissue.